Inventor · disambiguated record
Pnina Fishman
Also filed as: FISHMAN PNINA
22 granted patents·22 pending applications·94 citations·filing 1990–2023
94Inventor score
Files withCAN FITE BIOPHARMA LTD26FISHMAN PNINA6ARP BIOMED INC1ARP BIOMED LTD1CAN FITE BIOPHARAM LTD1
Top patents by PatentIndex Score
44 records- 0188US7825102B2Treatment of dry eye conditionsCAN FITE BIOPHARMA LTD·Filed 2006·Granted Nov 2, 2010·13 cites·15 claims
- 0283US9387220B2Method for inducing hepatocyte proliferation and uses thereofCAN FITE BIOPHARMA LTD·Filed 2014·Granted Jul 12, 2016·7 cites·19 claims
- 0382US7589075B2Use of an adenosine A3 receptor agonist for inhibition of viral replicationCAN FITE BIOPHARMA LTD·Filed 2002·Granted Sep 15, 2009·12 cites·16 claims
- 0480US6638914B1Pharmaceutical administration of adenosine agonistsCAN FITE BIOPHARMA LTD·Filed 2000·Granted Oct 28, 2003·18 cites·14 claims
- 0579US10265337B2Use of A3 adenosine receptor agonist in osteoarthritis treatmentCAN FITE BIOPHARMA LTD·Filed 2016·Granted Apr 23, 2019·2 cites·13 claims
- 0679US8987228B2Pharmaceutical composition including an A3 adenosine receptor agonist 1-deooxy-1-[N6-(3-idobenzyl)-adenin-9-yl]-N-methyl-β-D-ribofuronamide(IB-MECA/CF-101) for treatment of psoriasisFISHMAN PNINA·Filed 2010·Granted Mar 24, 2015·2 cites·12 claims
- 0776US8846635B2Method for inducing hepatocyte proliferation and uses thereofFISHMAN PNINA·Filed 2008·Granted Sep 30, 2014·3 cites·9 claims
- 0870US6790839B2Pharmaceutical administration of adenosine agonistsCAN FITE BIOPHARMA LTD·Filed 2001·Granted Sep 14, 2004·3 cites·11 claims
- 0969US7141553B2A3AR agonists for the treatment of inflammatory arthritisCAN FITE BIOPHARMA LTD ISRAEL·Filed 2003·Granted Nov 28, 2006·7 cites·4 claims
- 1065US11291681B2Method for treating fibrotic liver tissue using Cl-IB-MECACAN FITE BIOPHARMA LTD·Filed 2020·Granted Apr 5, 2022·0 cites·8 claims
- 1164US10780106B2Method for treating NASH accompanied by fibrosis using Cl-IB-MECACAN FITE BIOPHARMA LTD·Filed 2018·Granted Sep 22, 2020·0 cites·6 claims
- 1263US7465715B2Method for treatment of multiple sclerosisCAN FITE BIOPHARMA LTD·Filed 2004·Granted Dec 16, 2008·5 cites·4 claims
- 1363US2025387424A1Pharmaceutical composition comprising a3 adenosine receptor agonist for treatment of psoriasisCAN FITE BIOPHARMA LTD·Filed 2023·Application pending·0 cites
- 1462US8541182B2Biological marker for inflammationFISHMAN PNINA·Filed 2010·Granted Sep 24, 2013·1 cites·11 claims
- 1561US2023201240A1Treatment of advanced metastatic cancerCAN FITE BIOPHARMA LTD·Filed 2022·Application pending·0 cites
- 1652US5562902AImmunotherapeutic method of treating cancerous diseases by administration of intravenous immunoglobulinARP BIOMED INC·Filed 1994·Granted Oct 8, 1996·11 cites·10 claims
- 1752US2008300213A1Use of A3 Adenosine Receptor Agonist in Osteoarthritis TreatmentFISHMAN PNINA·Filed 2006·Application pending·0 cites
- 1852US2008292637A1Therapeutic Uses of A3 Adenosine Receptor AntibodiesFISHMAN PNINA·Filed 2006·Application pending·0 cites
- 1951US2005101560A1Method of treating an individual with methyl 1-[N6-(3-iodobenzyl)-adenin-9-yl] beta-D-ibofuronamideCAN FITE BIOPHARMA LTD·Filed 2003·Application pending·0 cites
- 2048US2013345163A1Biological marker for inflammationCAN FITE BIOPHARMA LTD·Filed 2013·Application pending·0 cites
- 2147US2005277615A1Pharmaceutical compositions having anti-inflammatory activityCAN FITE BIOPHARMA LTD·Filed 2004·Application pending·0 cites
- 2247US2008056992A1Biological Marker for InflammationCAN FITE BIOPHARMA LTD·Filed 2005·Application pending·0 cites
- 2346US2002165197A1Modulation of GSK-3beta activity and its different usesFiled 2002·Application pending·0 cites
- 2445US2023049415A1Cannabinoids for use in treatmentCAN FITE BIOPHARMA LTD·Filed 2021·Application pending·0 cites
- 2545US2002037871A1Pharmaceutical use of adenosine agonistsFiled 2001·Application pending·0 cites
- 2644US9549943B2A3 adenosine receptor ligands for use in treatment of a sexual dysfunctionCAN-FITE BIOPHARMA LTD·Filed 2013·Granted Jan 24, 2017·0 cites·17 claims
- 2744US2002115635A1Modulation of GSK-3beta activity and its different usesFiled 2001·Application pending·0 cites
- 2844US2008051365A1Treatment of InflammationCAN FITE BIOPHARMA LTD·Filed 2005·Application pending·0 cites
- 2944US2021069227A1A3 adenosine receptor ligand for managing cytokine release syndromeCAN FITE BIOPHARMA LTD·Filed 2018·Application pending·0 cites
- 3043US5965130AImmunotherapeutic method of treating cancerous diseases by administration of gamma globulinsARP BIOMED LTD·Filed 1995·Granted Oct 12, 1999·4 cites·18 claims
- 3143US2003143282A1Adenosine A3 receptor agonistFiled 2002·Application pending·0 cites
- 3242US12213990B2A3 adenosine receptor ligand for use for achieving a fat loss effectCAN FITE BIOPHARMA LTD·Filed 2020·Granted Feb 4, 2025·0 cites·5 claims
- 3342US2004229246A1Diagnostic markers for therapeutic treatmentCAN FITE BIOPHARAM LTD·Filed 2004·Application pending·0 cites
- 3440US6537587B1Compositions containing muscle-derived active agentsCAN FITE BIOPHARMA LTD·Filed 2000·Granted Mar 25, 2003·0 cites·5 claims
- 3539US2004204481A1Activation of natural killer cells by adenosine A3 receptor agonistsFiled 2001·Application pending·0 cites
- 3638US2004137477A1A3AR as a marker for a diseased stateCAN FITE BIOPHARMA LTD·Filed 2003·Application pending·0 cites
- 3738US2010222369A1Treatment for dry eye conditionsCAN FITE BIOPHARMA LTD·Filed 2010·Application pending·0 cites
- 3836US6911435B1Method of treating leukopenia with adenosineCAN FITE BIOPHARMA LTD·Filed 1998·Granted Jun 28, 2005·2 cites·15 claims
- 3935US2015018299A1Treatment of liver conditionsCAN FITE BIOPHARMA LTD·Filed 2013·Application pending·0 cites
- 4035US2013045943A1A3ar agonists for the treatment of uveitisUS GOV HEALTH & HUMAN SERV·Filed 2011·Application pending·0 cites
- 4134US8557790B2A3 adenoside receptor agonists for the reduction of intraocular pressureFISHMAN PNINA·Filed 2010·Granted Oct 15, 2013·0 cites·13 claims
- 4234US5242692AAnti-metastatic factorUNIV BAR ILAN·Filed 1990·Granted Sep 7, 1993·3 cites·6 claims
- 4334US2006241069A1Treatment of hyperproliferative diseaseCAN FITE BIOPHARMA LTD·Filed 2005·Application pending·0 cites
- 4419US5962331ACell growth regulatorCAN FITE TECHNOLOGIES LTD·Filed 1995·Granted Oct 5, 1999·1 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when Pnina Fishman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →